Publications

Detailed Information

Reduction in the protein level of c-Jun and phosphorylation of Ser73-c-Jun in rat frontal cortex after repeated MK-801 treatment

Cited 6 time in Web of Science Cited 6 time in Scopus
Authors

Ahn, Yong Min; Seo, Myoung Suk; Kim, Se Hyun; Jeon, Won Je; Kang, Ung Gu; Kim, Yong Sik; Juhnn, Yong-Sung; Kim, Yeni

Issue Date
2009-05-15
Publisher
ELSEVIER IRELAND LTD
Citation
PSYCHIATRY RESEARCH; Vol.167 01월 02일; 80-87
Keywords
JNKMAPKNMDA receptor antagonistPsychotomimetic agentPsychosis
Abstract
Repeated administration of NMDA antagonists can induce behavioral alterations that mimic symptoms of psychosis, as seen in schizophrenia. JNK, one of the MAPKs, and c-Jun, its downstream target molecule, play important roles in regulating apoptosis in neural cells, and have been suggested as being associated with the pathophysiology of psychosis and the mechanism of action of some antipsychotics. We investigated changes in the JNK-c-Jun pathway and other Jun family proteins in the rat frontal cortex after single and repeated administration of MK-801 to examine acute and chronic responses. Neither the protein level nor the phosphorylation of JNK changed after single or repeated doses of MK-801. However, after repeated treatments, but not a single treatment, with MK-801, a down-regulation occurred in the protein level and of Ser73 phosphorylation of c-Jun in the rat frontal cortex. Other members of the Jun family, JunB and JunD, were unchanged. Repeated exposure to MK-801 down-regulated the phosphorylation and protein level of c-Jun in the rat frontal cortex, which may be related to the long-term effects of chronic treatment with MK-801. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
ISSN
0165-1781
Language
English
URI
https://hdl.handle.net/10371/76856
DOI
https://doi.org/10.1016/j.psychres.2007.12.013
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share